Marker Therapeutics, Inc. (MRKR)
0.9466
-0.06
(-6.28%)
USD |
NASDAQ |
Oct 13, 16:00
0.9466
0.00 (0.00%)
After-Hours: 18:01
Marker Therapeutics Price to Book Value : 1.297 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.384 |
| October 09, 2026 | 1.332 |
| October 08, 2026 | 1.302 |
| October 07, 2026 | 1.425 |
| October 06, 2026 | 1.384 |
| October 05, 2026 | 1.453 |
| October 02, 2026 | 1.439 |
| October 01, 2026 | 1.439 |
| September 30, 2026 | 1.466 |
| September 29, 2026 | 1.508 |
| September 28, 2026 | 1.542 |
| September 25, 2026 | 1.576 |
| September 24, 2026 | 1.631 |
| September 23, 2026 | 1.699 |
| September 22, 2026 | 1.672 |
| September 21, 2026 | 1.645 |
| September 18, 2026 | 1.617 |
| September 17, 2026 | 1.617 |
| September 16, 2026 | 1.562 |
| September 15, 2026 | 1.604 |
| September 14, 2026 | 1.604 |
| September 11, 2026 | 1.576 |
| September 10, 2026 | 1.645 |
| September 09, 2026 | 1.658 |
| September 08, 2026 | 1.754 |
| Date | Value |
|---|---|
| September 04, 2026 | 1.617 |
| September 03, 2026 | 1.699 |
| September 02, 2026 | 1.713 |
| September 01, 2026 | 1.782 |
| August 31, 2026 | 1.823 |
| August 28, 2026 | 1.878 |
| August 27, 2026 | 2.001 |
| August 26, 2026 | 1.987 |
| August 25, 2026 | 2.083 |
| August 24, 2026 | 2.056 |
| August 21, 2026 | 1.905 |
| August 20, 2026 | 1.672 |
| August 19, 2026 | 1.768 |
| August 18, 2026 | 1.576 |
| August 17, 2026 | 1.590 |
| August 14, 2026 | 1.562 |
| August 13, 2026 | 1.521 |
| August 12, 2026 | 1.590 |
| August 11, 2026 | 1.535 |
| August 10, 2026 | 1.576 |
| August 07, 2026 | 1.535 |
| August 06, 2026 | 1.535 |
| August 05, 2026 | 1.562 |
| August 04, 2026 | 1.686 |
| August 03, 2026 | 1.672 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.453 |
| Alnylam Pharmaceuticals, Inc. | 22.10 |
| Anika Therapeutics, Inc. | 1.996 |
| Savara, Inc. | 6.827 |
| Vericel Corp. | 5.576 |
Price to Book Value Related Metrics
| PS Ratio | 7.299 |
| Price | 0.9466 |
| Earnings Yield | -50.78% |
| Market Cap | 15.78M |